SUNNYVALE, Calif.
Labcyte Inc., the company revolutionizing life science research with the Echo® acoustic liquid handler, was recognized by the World Economic Forum for demonstrating the ability to inspire and leverage creativity to develop transformative solutions. The recognition is based on Labcyte’s innovative use of sound energy to transfer liquids. Their technology has enabled scientists to discover new therapeutics, improve diagnostics and better prescribe targeted, patient-specific treatments.
Each year since 2000, the World Economic Forum has chosen a select number of Technology Pioneers from hundreds of applicants. Candidate companies are nominated by members, constituents and collaborators of the World Economic Forum and by the public. The 82-member selection committee – composed of distinguished technology and innovation experts, academics and venture capitalists – reviews each application before making its recommendation to the World Economic Forum.
“Acoustic liquid handling is a major leap forward from traditional liquid handling systems,” said Mark Fischer-Colbrie, president and CEO of Labcyte Inc. “The ability to transfer liquids containing drugs, cells, DNA, assay reagents and other materials with great precision and accuracy – in increments as low as a billionth of a liter – can be used in hundreds of applications across all areas of life science research. Use of acoustic energy to avoid all of the deficiencies of pipetting has already resulted in discoveries of new drug-candidates, lower costs of molecular diagnostics and better selection of therapeutics for targeted patient treatment. The Echo liquid handler is used today by the world’s top pharmaceutical firms, academic institutions, genome centers, contract research organizations and diagnostic providers. It is the future of life science.”
“The impact of technology continues to accelerate in all domains of society,” said Fulvia Montresor, Director, Head of Technology Pioneers at the World Economic Forum. “To better understand the breadth and depth of this impact, CEOs and other leaders have come to depend on their interactions with the Technology Pioneers and their diverse and innovative solutions.”
Labcyte will be recognized for its achievements in a ceremony on September 11, at the eighth Annual Meeting of the New Champions in Tianjin, China. The Meeting is the foremost gathering in Asia on science, technology, innovation and entrepreneurship. It will bring together more than 1,500 leaders from business, government and research from over 90 countries. In addition to the Technology Pioneers, participants will also include the Forum’s Global Growth Companies, Young Global Leaders, Young Scientists, Social Entrepreneurs and Global Shapers, as well as its Members and Partners.
View video interview with Labcyte CEO, Mark Fischer-Colbrie and Founder and CTO, Rich Ellson.
More information about the World Economic Forum’s Technology Pioneers program can be found at http://www.weforum.org/techpioneers.
About Labcyte
Labcyte, a global biotechnology tools company headquartered in Sunnyvale, California, is revolutionizing liquid handling. Echo liquid handling systems use sound to precisely transfer liquids without contact, eliminating the use of pipettes. Labcyte instruments are used worldwide throughout the pharmaceutical industry, diagnostic companies, genome centers, genomic service companies, biotechnology firms, contract research organizations, and academic institutions. Our customers work across a wide spectrum of scientific research, including drug discovery, genomics, proteomics, diagnostics, precision medicine, and imaging mass spectrometry. Labcyte has 53 U.S. patents and others internationally. For more information, visit www.labcyte.com.
CONTACT
Labcyte Inc.
Pamela Lo, +1 408-747-2000 ext. 211
pamela.lo@labcyte.com
1190
Borregas Avenue
Sunnyvale, CA 94089
